265 related articles for article (PubMed ID: 34406042)
21. HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs.
Zhang JP; Yang ZX; Zhang F; Fu YW; Dai XY; Wen W; Zhang B; Choi H; Chen W; Brown M; Baylink D; Zhang L; Qiu H; Wang C; Cheng T; Zhang XB
Sci China Life Sci; 2021 Sep; 64(9):1449-1462. PubMed ID: 33420926
[TBL] [Abstract][Full Text] [Related]
22. Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.
Fu YW; Dai XY; Wang WT; Yang ZX; Zhao JJ; Zhang JP; Wen W; Zhang F; Oberg KC; Zhang L; Cheng T; Zhang XB
Nucleic Acids Res; 2021 Jan; 49(2):969-985. PubMed ID: 33398341
[TBL] [Abstract][Full Text] [Related]
23. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
24. Combi-CRISPR: combination of NHEJ and HDR provides efficient and precise plasmid-based knock-ins in mice and rats.
Yoshimi K; Oka Y; Miyasaka Y; Kotani Y; Yasumura M; Uno Y; Hattori K; Tanigawa A; Sato M; Oya M; Nakamura K; Matsushita N; Kobayashi K; Mashimo T
Hum Genet; 2021 Feb; 140(2):277-287. PubMed ID: 32617796
[TBL] [Abstract][Full Text] [Related]
25. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair.
Gutschner T; Haemmerle M; Genovese G; Draetta GF; Chin L
Cell Rep; 2016 Feb; 14(6):1555-1566. PubMed ID: 26854237
[TBL] [Abstract][Full Text] [Related]
26. Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion.
Wen W; Quan ZJ; Li SA; Yang ZX; Fu YW; Zhang F; Li GH; Zhao M; Yin MD; Xu J; Zhang JP; Cheng T; Zhang XB
Genome Biol; 2021 Aug; 22(1):236. PubMed ID: 34416913
[TBL] [Abstract][Full Text] [Related]
27. Improved and Flexible HDR Editing by Targeting Introns in iPSCs.
Fu J; Fu YW; Zhao JJ; Yang ZX; Li SA; Li GH; Quan ZJ; Zhang F; Zhang JP; Zhang XB; Sun CK
Stem Cell Rev Rep; 2022 Jun; 18(5):1822-1833. PubMed ID: 35089463
[TBL] [Abstract][Full Text] [Related]
28. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of CRISPR-Cas9 induced precise gene editing by targeting histone H2A-K15 ubiquitination.
Bashir S; Dang T; Rossius J; Wolf J; Kühn R
BMC Biotechnol; 2020 Oct; 20(1):57. PubMed ID: 33097066
[TBL] [Abstract][Full Text] [Related]
30. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
[TBL] [Abstract][Full Text] [Related]
31. One-step knock-in of two antimicrobial peptide transgenes at multiple loci of catfish by CRISPR/Cas9-mediated multiplex genome engineering.
Wang J; Torres IM; Shang M; Al-Armanazi J; Dilawar H; Hettiarachchi DU; Paladines-Parrales A; Chambers B; Pottle K; Soman M; Su B; Dunham RA
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129384. PubMed ID: 38224812
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
[TBL] [Abstract][Full Text] [Related]
33. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
34. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
35. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
Dettmer R; Naujok O
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
[TBL] [Abstract][Full Text] [Related]
36. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage.
Zhang JP; Li XL; Li GH; Chen W; Arakaki C; Botimer GD; Baylink D; Zhang L; Wen W; Fu YW; Xu J; Chun N; Yuan W; Cheng T; Zhang XB
Genome Biol; 2017 Feb; 18(1):35. PubMed ID: 28219395
[TBL] [Abstract][Full Text] [Related]
37. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9 Genome Engineering in Human Pluripotent Stem Cells for Modeling of Neurological Disorders.
Canals I; Ahlenius H
Methods Mol Biol; 2021; 2352():237-251. PubMed ID: 34324191
[TBL] [Abstract][Full Text] [Related]
39. CRISPR-Cas9-Mediated Gene Editing in Mouse Spermatogonial Stem Cells.
Wang Y; Ding Y; Li J
Methods Mol Biol; 2017; 1622():293-305. PubMed ID: 28674816
[TBL] [Abstract][Full Text] [Related]
40. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
